cytosine has been researched along with Chronic Hepatitis B in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The concentrations in plasma declined in a biexponential manner after intravenous administration, with a long terminal-phase half-life of 5." | 1.32 | Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine. ( Chen, H; Chu, CK; Feitelson, M; Glazkova, Y; Hurwitz, SJ; McClure, HM; Pai, SB; Schinazi, RF, 2003) |
| "Worldwide, hepatocellular carcinoma (HCC) is more prevalent in men than in women, suggesting that sex hormones and/or X-chromosome-linked genes may be involved in hepatocarcinogenesis." | 1.31 | Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. ( Chang, HC; Chen, CJ; Chen, PJ; Cheng, SW; Hsiao, TJ; Lee, SD; Liaw, YF; Lin, MW; Lin, SM; Liu, CJ; Yang, SY; Yu, MW, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madeddu, G | 1 |
| Ortu, S | 1 |
| Garrucciu, G | 1 |
| Maida, I | 1 |
| Melis, M | 1 |
| Muredda, AA | 1 |
| Mura, MS | 1 |
| Babudieri, S | 1 |
| Papatheodoridis, GV | 1 |
| Lampertico, P | 1 |
| Manolakopoulos, S | 1 |
| Lok, A | 1 |
| Chen, H | 1 |
| Pai, SB | 1 |
| Hurwitz, SJ | 1 |
| Chu, CK | 1 |
| Glazkova, Y | 1 |
| McClure, HM | 1 |
| Feitelson, M | 1 |
| Schinazi, RF | 1 |
| Li, HQ | 1 |
| Li, Z | 1 |
| Liu, Y | 1 |
| Li, JH | 1 |
| Dong, JQ | 1 |
| Gao, JR | 1 |
| Gou, CY | 1 |
| Li, H | 1 |
| Yu, MW | 1 |
| Cheng, SW | 1 |
| Lin, MW | 1 |
| Yang, SY | 1 |
| Liaw, YF | 1 |
| Chang, HC | 1 |
| Hsiao, TJ | 1 |
| Lin, SM | 1 |
| Lee, SD | 1 |
| Chen, PJ | 1 |
| Liu, CJ | 1 |
| Chen, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Study of mRNA Vaccine for Patients With HBV-positive Advanced Hepatocellular Carcinoma[NCT05738447] | Phase 1 | 9 participants (Anticipated) | Interventional | 2023-02-15 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cytosine and Chronic Hepatitis B
| Article | Year |
|---|---|
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cytosine; Female; Hepatitis B, Chronic; Humans; | 2010 |
4 other studies available for cytosine and Chronic Hepatitis B
| Article | Year |
|---|---|
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy.
Topics: Adenine; Aged; Antiviral Agents; Cross-Sectional Studies; Cytosine; DNA (Cytosine-5-)-Methyltransfer | 2017 |
Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.
Topics: Animals; Antiviral Agents; Cytosine; DNA Replication; DNA, Viral; Female; Hepatitis B virus; Hepatit | 2003 |
Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.
Topics: Adenine; Adult; Case-Control Studies; Cytosine; Female; Genotype; Hepatitis B; Hepatitis B virus; He | 2005 |
Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma.
Topics: Adenine; Adult; Aged; Carcinoma, Hepatocellular; Case-Control Studies; Cohort Studies; Cytosine; Gua | 2000 |